| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | iopromide | FAERS: 206 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 2 | Iohexol | FAERS: 154 Canada Vigilance: 32 | Canada Vigilance SIDER US FAERS | |
| 3 | Gadolinium DTPA | FAERS: 135 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 4 | Iopamidol | FAERS: 101 Canada Vigilance: 15 | Canada Vigilance SIDER US FAERS | |
| 5 | gadobutrol | FAERS: 74 Canada Vigilance: 11 | Canada Vigilance US FAERS | |
| 6 | gadobenic acid | FAERS: 69 Canada Vigilance: 6 | Canada Vigilance US FAERS | |
| 7 | ioversol | FAERS: 56 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 8 | iodixanol | FAERS: 45 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 9 | gadoteridol | FAERS: 18 | US FAERS | |
| 10 | FS 069 | FAERS: 17 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 11 | gadoterate meglumine | FAERS: 16 | US FAERS | |
| 12 | Isotretinoin | FAERS: 12 | US FAERS | |
| 13 | Gadolinium | FAERS: 11 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 14 | gadodiamide | FAERS: 11 | US FAERS | |
| 15 | ioxilan | FAERS: 8 | US FAERS | |
| 16 | Barium Sulfate | FAERS: 5 | US FAERS | |
| 17 | contrast agent BR1 | FAERS: 5 | US FAERS | |
| 18 | gadolinium ethoxybenzyl DTPA | FAERS: 5 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 19 | rofecoxib | FAERS: 4 | US FAERS | |
| 20 | Gadobenic acid | FAERS: 3 | US FAERS | |
| 21 | Technetium Tc 99m oxidronate | FAERS: 3 | US FAERS | |
| 22 | Ablavar | FAERS: 2 | US FAERS | |
| 23 | Baclofen | FAERS: 2 | US FAERS | |
| 24 | Bosentan | FAERS: 2 | US FAERS | |
| 25 | Fluorescein | FAERS: 2 | US FAERS | |
| 26 | Glatiramer Acetate | FAERS: 2 | US FAERS | |
| 27 | Indocyanine Green | FAERS: 2 | US FAERS | |
| 28 | Iodine | FAERS: 2 | US FAERS | |
| 29 | Iothalamate Meglumine | FAERS: 2 | US FAERS | |
| 30 | Ioxaglic Acid | FAERS: 2 | US FAERS | |
| 31 | Lisinopril | FAERS: 2 | US FAERS | |
| 32 | NuvaRing | FAERS: 2 | US FAERS | |
| 33 | Topiramate | FAERS: 2 | US FAERS | |
| 34 | gadoversetamide | FAERS: 2 | US FAERS | |
| 35 | regadenoson | FAERS: 2 | US FAERS | |
| 36 | 2-(Tert-butylamino)-1-(3-chlorophenyl)propan-1-one;hydron;chloride | FAERS: 1 | US FAERS | |
| 37 | 2-[4,7-Bis(carboxylatomethyl)-10-(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetate;gadolinium(3+) | FAERS: 1 | US FAERS | |
| 38 | Acidum gadopenteticum | FAERS: 1 | US FAERS | |
| 39 | Anastrozole | FAERS: 1 | US FAERS | |
| 40 | Axitinib | FAERS: 1 | US FAERS | |
| 41 | Copper | FAERS: 1 | US FAERS | |
| 42 | Diatrizoate | FAERS: 1 | SIDER US FAERS | |
| 43 | Disodium;2-(3-oxido-6-oxoxanthen-9-yl)benzoate | FAERS: 1 | US FAERS | |
| 44 | Everolimus | FAERS: 1 | US FAERS | |
| 45 | Glyburide | FAERS: 1 | US FAERS | |
| 46 | Haloperidol | FAERS: 1 | US FAERS | |
| 47 | Iopanoic Acid | FAERS: 1 | US FAERS | |
| 48 | Mebrofenin | FAERS: 1 | US FAERS | |
| 49 | Meperidine | FAERS: 1 | US FAERS | |
| 50 | Methylene Blue | FAERS: 1 | US FAERS | |
| 51 | Methylprednisolone Hemisuccinate | FAERS: 1 | US FAERS | |
| 52 | Nafcillin | FAERS: 1 | US FAERS | |
| 53 | Pramipexole | FAERS: 1 | US FAERS | |
| 54 | Raloxifene Hydrochloride | FAERS: 1 | US FAERS | |
| 55 | Rosiglitazone | FAERS: 1 | US FAERS | |
| 56 | Ruxolitinib phosphate | FAERS: 1 | US FAERS | |
| 57 | Sincalide | FAERS: 1 | US FAERS | |
| 58 | Sitagliptin Phosphate | FAERS: 1 | US FAERS | |
| 59 | Thalidomide | FAERS: 1 | US FAERS | |
| 60 | Ticagrelor | FAERS: 1 | US FAERS | |
| 61 | Vancomycin | FAERS: 1 | US FAERS | |
| 62 | gadobutrol | FAERS: 1 | US FAERS | |
| 63 | gadolinium ethoxybenzyl DTPA | FAERS: 1 | US FAERS | |
| 64 | palbociclib | FAERS: 1 | US FAERS | |
| 65 | rucaparib | FAERS: 1 | US FAERS | |
| 66 | suvorexant | FAERS: 1 | US FAERS | |
| 67 | ziprasidone | FAERS: 1 | US FAERS |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120326
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.